Skip to main content
. 2017 Oct 6;21(3):207–215. doi: 10.1093/ijnp/pyx089

Table 2.

Demographic and Clinical Data for the Participants in Cohort 2

SZ MDD BD Control Statistics
Number (male/female) 115 (59/56) 45 (19/26) 71 (37/34) 90 (46/54) P=.72 a
Age, years (mean±SD) 39.0±13.6 50.4±16.0 45.2±13.3 49.2±15.0 P=.000046 b
Number of drug-free patients (male/female) 7 (5/2) 4 (3/1) 0 N.A. N.A.
Number of patients with depressed state N.A. 34 25 N.A. N.A.
Number of patients with remitted state N.A. 11 34 N.A. N.A.
Number of patients with manic state N.A. N.A. 12 N.A. N.A.
HAMD-21, score (mean ±SD) N.A. 17.0±8.6 9.2±8.1 N.A. N.A
PANSS positive, score (mean ±SD) 17.7±5.6 N.A. N.A. N.A. N.A.
PANSS negative, score (mean±SD) 18.7±6.2 N.A. N.A. N.A. N.A.
PANSS general pathology, score (mean ±SD) 36.0±8.7 N.A. N.A. N.A. N.A.
YMRS, score (mean ±SD) N.A. N.A. 5.7±7.4 N.A. N.A.

Abbreviations: BD, bipolar disorder; HAMD-21, 21-item Hamilton Depression Rating Scale; MDD, major depressive disorder; N.A., not applicable; PANSS, Positive and Negative Symptom Scale; SZ, schizophrenia; YMRS, Young Mania Rating Scale.

aChi-squared test.

bANOVA.